From the Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care & Neuropediatrics, Medical University of Vienna.
Center for Anthropogenic Infections, Division for Public Health, Austrian Agency for Health and Food Safety.
Pediatr Infect Dis J. 2019 Jun;38(6):638-642. doi: 10.1097/INF.0000000000002258.
The Gram-negative bacterium Klebsiella pneumoniae is a frequent pathogen causing outbreaks in neonatal intensive care units. Some Enterobacteriaceae can acquire the ability to sequester iron from infected tissue by secretion of iron-chelating compounds such as yersiniabactin. Here we describe an outbreak and clinical management of infections because of a highly virulent yersiniabactin-producing, nonmultiresistant K. pneumoniae strain in a neonatal intensive care unit. Outbreak investigation and effectiveness assessment of multidisciplinary infection control measurements to prevent patient-to-patient transmission of highly pathogenic K. pneumoniae were undertaken.
Outbreak cases were identified by isolation of K. pneumoniae from blood or stool of infants. Clinical data were abstracted from medical charts. K. pneumoniae isolates were genotyped using whole genome sequencing, and yersiniabactin production was evaluated by luciferase assay.
Fourteen cases were confirmed with 8 symptomatic and 6 colonized patients. Symptomatic patients were infants of extremely low gestational and chronologic age with fulminant clinical courses including necrotizing enterocolitis and sepsis. Whole genome sequencing for bacterial isolates confirmed the presence of an outbreak. All outbreak isolates produced yersiniabactin.
Yersiniabactin-producing K. pneumoniae can display a high pathogenicity in extremely premature infants with low chronologic age. This outbreak also underlines the considerable potential of today's infection control systems for recognizing and controlling nosocomial infections in highly vulnerable populations.
革兰氏阴性菌肺炎克雷伯菌是一种常见的病原体,经常导致新生儿重症监护病房爆发感染。某些肠杆菌科细菌可以通过分泌铁螯合化合物(如耶尔森菌素)从感染组织中获取铁。在这里,我们描述了一起新生儿重症监护病房中发生的、由高毒力耶尔森菌素产生、非多耐药肺炎克雷伯菌菌株引起的感染暴发和临床处理。我们对多学科感染控制措施的效果进行了评估,以防止高致病性肺炎克雷伯菌在患者之间传播。
通过从血液或粪便中分离肺炎克雷伯菌,鉴定暴发病例。从病历中提取临床数据。使用全基因组测序对肺炎克雷伯菌分离株进行基因分型,并通过荧光素酶测定评估耶尔森菌素的产生。
共确诊 14 例病例,其中 8 例为有症状患者,6 例为定植患者。有症状的患者是极低胎龄和极早产儿,临床病程暴发性,包括坏死性小肠结肠炎和败血症。对细菌分离株进行全基因组测序证实了暴发的存在。所有暴发分离株均产生耶尔森菌素。
产耶尔森菌素的肺炎克雷伯菌在低胎龄极低出生体重儿中可能表现出较高的致病性。此次暴发还突出表明了当今感染控制系统在识别和控制高度脆弱人群医院感染方面的巨大潜力。